AVEN antibody (AA 203-362)
Quick Overview for AVEN antibody (AA 203-362) (ABIN6137375)
Target
See all AVEN AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 203-362
-
Sequence
- VQGTVPLEVP QVKPKRTDDG KGLGMQLKGP LGPGGRGPIF ELKSVAAGCP VLLGKDNPSP GPSRDSQKPT SPLQSAGDHL EEELDLLLNL DAPIKEGDNI LPDQTSQDLK SKEDGEVVQE EEVCAKPSVT EEKNMEPEQP STSKNVTEEE LEDWLDSMIS
-
Cross-Reactivity
- Human, Rat
-
Characteristics
- Polyclonal Antibodies
-
Purification
- Affinity purification
-
Immunogen
- Recombinant fusion protein containing a sequence corresponding to amino acids 203-362 of human AVEN (NP_065104.1).
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB,1:1000 - 1:3000,IF,1:50 - 1:200
-
Comment
-
HIGH QUALITY
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- AVEN (Apoptosis, Caspase Activation Inhibitor (AVEN))
-
Alternative Name
- AVEN
-
Background
- Protects against apoptosis mediated by Apaf-1.,AVEN,PDCD12,Epigenetics & Nuclear Signaling,Cancer,Tumor biomarkers,Cell Biology & Developmental Biology,Apoptosis,Caspases,AVEN
-
Molecular Weight
- 38 kDa
-
Gene ID
- 57099
-
UniProt
- Q9NQS1
Target
-